From the New York Times article on pharma-boys arrest

The investigation, in which Mr. Shkreli has been charged with securities fraud, is related to his time as a hedge fund manager and running the biopharmaceutical company Retrophin — not the price-gouging controversy that has swirled around him.

Why do I get the feeling that once he started price-gouging someone pointed the Feds at his previous activity?